Hexo Corp nice looking Cannabis penny stocksHexo stock’s recent surge in price has made me look good—I’ve long championed this stock as one of my favorite

Hexo Corp nice looking Cannabis penny stocks

Hexo Corp nice looking Cannabis penny stocksHexo stock’s recent surge in price has made me look good—I’ve long championed this stock as one of my favorite picks in the entire weed stock market. HYYDF stock has jumped by 31% over the past five days, adding another strong gain of seven percent in early-morning trading today. […]

Continue Reading
The Supreme Cannabis Company, Inc.Supreme Cannabis, announces that as of calendar year-end, 7ACRES has 19 completed flowering roomsis on track

SUPREME CANNABIS PROVIDES CONSTRUCTION UPDATE FOR 7ACRES

As of calendar year-end, 7ACRES has 19 completed flowering rooms Completion of all 25 flowering rooms scheduled for March 2019 Administrative offices and other facilities scheduled for completion by mid-2019 Health Canada approval of additional flowering rooms expected in the near term  The Supreme Cannabis Company, Inc.(“Supreme Cannabis” or the “Company”) (TSXV: FIRE) (OTCQX: SPRWF) […]

Continue Reading
The way people receive health care, including Medical Cannabis is evolving. Advancements in telemedicine and artificial intelligence

Health Care + Medical Cannabis = POTENTIAL BIG WIN FOR INVESTORS!

The way people receive health care, including Medical Cannabis is evolving. Advancements in telemedicine and artificial intelligence are making way for innovative health care approaches that combine human skill-based expertise with emerging technologies. THE PROBLEM: The Health Care System is Dated & Broken!Medical Cannabis Rising Costs: Governments and payors facing increasing costs that are simply unsustainable. […]

Continue Reading
The cannabis industry has come a long way in a very short period of time. During the mid-2000s, just a third of all Americans polled by Gallup favored

Cannabis Stocks Set to Benefit from Wave of Good News

The cannabis industry has come a long way in a very short period of time. During the mid-2000s, just a third of all Americans polled by Gallup favored the idea of legalizing marijuana on a national level. As of 2018, 2 out of every 3 Americans favor legalization. This favorability toward cannabis is a big […]

Continue Reading
Aphria is a leading global cannabis company

APHRIA COMPLETES SECOND MEDICAL CANNABIS SHIPMENT TO AUSTRALIA-BASED PARTNER ALTHEA

Aphria Inc. announced. that the Company has completed its second shipment of approximately 80 L (equivalent to approximately 20 kg of dried bud) of medical cannabis to its Australian-based partner Althea Company Pty Ltd. (“Althea“). Under a previously announced supply agreement with Althea (the “Agreement“), Aphria is providing packaged co-branded cannabis oil and dried flower products for the Australian medical […]

Continue Reading
Cool Beer Brewery continues to expand operations across multiple (regulated) beverage segments. Cool already has multiple federal and

COOL CANNABIS – COOL BREWERY WAITING FOR PROCESSING LICENSE FROM HEALTH CANADA

 Cool Beer Brewery continues to expand operations across multiple (regulated) beverage segments. Cool already has multiple federal and provincial licensees to produce and package beer, wine, ciders and coolers; Cool is now looking to expand their business to include infused (cannabis based) beverages. “At the start of the year we applied for our processing license from […]

Continue Reading
fandomfare gaming Aphria Signs Letter of Intent with Insumos Medicos

Aphria Signs Letter of Intent for Exclusive Supply Agreement with Insumos Medicos, S.A. to Supply Medical Cannabis in Paraguay

Aphria Inc.today announced that it has signed a Letter of Intent (the “LOI”) with Insumos Medicos S.A. (“Insumos”), a Paraguayan pharmaceutical manufacturing, import and distribution company, to enter into an exclusive supply and distribution agreement to provide medical cannabis in Paraguay. “Latin America continues to represent an important growth opportunity within the global medical cannabis […]

Continue Reading

Ontario poised to allow private cannabis retail

Ontario poised to allow private cannabis retail   Cannabis at a glance Ontario poised to allow private cannabis retail   The Ontario government will purportedly enable private stores to offer weed once recreational cannabis ends up legitimate on Oct. 17. A source in the common government told the Globe and Mail that Finance Minister Vic Fedeli […]

Continue Reading
The Cannabis industry remains volatile, and inconsistent regulations can make expansion difficult. Nonetheless, in 2018 the cannabis industry in states like California are still finding their footing on many fronts with both a regulatory framework and banking solution being very much under construction. As these normalize, companies will be able to establish their business metrics and get a firmer idea of the size of their opportunity, and then naturally increased M&A activity will follow, as has been the norm in other states, like Oregon, Nevada and Colorado. These companies could benefit from an increase in M&A in the Legal Cannabis space: Nightfood Hldgs Inc. (OTC: NGTF), INSYS Therapeutics, Inc . (NASDAQ: INSY), GW Pharmaceuticals Plc. (NASDAQ: GWPH), Tilray, Inc. (NASDAQ: TLRY), The Scotts Miracle-Gro Company (NYSE: SMG) Nightfood Hldgs Inc. (OTCPK: NGTF) Market Cap: $15.28M, current share price: $.36 NightFood manufactures and distributes better-for-you snacks specifically formulated to satisfy unhealthy nighttime cravings in a better, healthier, more sleep-friendly way. Future product line extensions may include formats such as NightFood cookies, NightFood ice cream, NightFood bites, and more. In addition, MJ Munchies, Inc. was recently formed as a new, wholly owned subsidiary, to exploit legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the Half-Baked™ brand name. As the legal landscape around CBD and cannabis related products continue to change and evolve, MJ Munchies will continue to explore, identify, and hope to capitalize on opportunities clearly defined as legal. INSYS Therapeutics, Inc . (NASDAQ: INSY) Market Cap: $559.47M, current share price: $7.58 Insys Therapeutics, Inc., is a specialty pharmaceutical company, develops and commercializes supportive care products. The company markets SUBSYS, a sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant adult patients; and SYNDROS, an orally administered liquid formulation of dronabinol for the treatment of chemotherapy-induced nausea and vomiting, and anorexia associated with weight loss in patients with AIDS. It is also developing Cannabidiol Oral Solution, which has completed pediatric study for the treatment of pediatric epilepsy; has completed Phase II study to treat west syndrome; and is in Phase II study for the treatment of childhood absence epilepsy, as well as Buprenorphine Sublingual Spray that has completed Phase III study to treat acute pain. In addition, the company is developing Cannabidiol Oral Solution for the treatment of prader willi. GW Pharmaceuticals Plc. (NASDAQ: GWPH) Market Cap: $4.26B, current share price: $151.15 GW Pharmaceuticals plc, is a biopharmaceutical company, engages in discovering, developing, and commercializing cannabinoid prescription medicines using botanical extracts derived from the Cannabis plant. The company operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. Its lead product is Epidiolex, an oral medicine which is in Phase III clinical development for the treatment of efractory childhood epilepsies, as well as for the treatment of Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, and infantile spasms. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. In addition, it develops various product candidates, which are in Phase I and II clinical development for the treatment of glioma, neonatal hypoxic-ischemic encephalopathy, adult epilepsy, and schizophrenia. Tilray, Inc. (NASDAQ: TLRY) Market Cap: 2.73B, current share price: $29.77 Tilray, Inc. IPO'd on Thursday July, 19th, at around $20 per share. Shares then spiked at a high of just over $34 a share, before declining in recent sessions to end trading today at $25.36. Tilray, Inc. is a vertically-integrated and federally-licensed cannabis cultivator, processor and distributor. On July 23rd the company announced the closing of its IPO, and full exercise of the underwriters' option to purchase additional shares. The Scotts Miracle-Gro Company (NYSE: SMG) Market Cap: 4.51B, current share price: $81.56 The Scotts Miracle-Gro Company manufactures, markets, and sells consumer lawn and garden products. The company operates through three segments: U.S. Consumer, Hawthorne, and Other. It offers lawn care products, including lawn fertilizers, grass seed products, spreaders, other durable products, and outdoor cleaners, as well as lawn-related weed, pest, and disease control products. The company also provides gardening and landscape products, such as water soluble and continuous-release plant foods, potting mixes and garden soils, mulch and decorative groundcover products, plant-related pest and disease control products, organic garden products, and live goods and seeding solutions. In addition, it offers hydroponic products that help users grow plants, flowers, and vegetables in an indoor or urban environment; and insect control products, rodent control products, and weed control products for home areas. The company offers its products under the Scotts, Turf Builder, EZ Seed, LiquaFeed, Water Smart, PatchMaster, GrubEx, EdgeGuard, Snap, Handy Green II, Scotts OxiCleanTM3, Miracle-Gro, Osmocote, Hyponex, Earthgro, SuperSoil, Ortho, Nature Scape, Miracle-Gro Organic Choice, Nature's Care, Whitney Farms, EcoScraps, Gro-ables, General Hydroponics, Gavita, AeroGarden, Botanicare, Vermicrop, Agrolux, Can-Filters, Fafard, Ortho, Tomcat, Roundup, and Groundclear brand names.

Cannabis Mergers, Acquisitions, and IPOs

Cannabis Mergers, Acquisitions, and IPOs   Cannabis Mergers The Cannabis industry remains volatile, and inconsistent regulations can make expansion difficult. Nonetheless, in 2018 the cannabis industry in states like California are still finding their footing on many fronts with both a regulatory framework and banking solution being very much under construction. As these normalize, companies will be […]

Continue Reading
could Canada Cannabis branding restrictions hurt Stock Prices

Daily cannabis News; Canada Cannabis branding restrictions could hurt Stock Prices

Daily cannabis News; Canada Cannabis branding restrictions could hurt Stock Prices Daily cannabis News In the pot news today is the likelihood that marking limitations on the Cannabis business by Health Canada could adversely affect cannabis stock deals and future esteem. The issue is that Canada, while being the most weed-accommodating nation in the created […]

Continue Reading